RxDoctor Payments Data

Abel Murillo, MD

Pain Medicine · Miami, FLNPI 1063490852

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,175 of the $2,480 with a category attached, or 87.7%. 19 manufacturers reported payments, led by Curonix LLC at 25.5% of the total. Reporting peaked in 2023 at $742 and has fallen 78.6% since, to $159 in 2025. That places this record below the midpoint for pain medicine clinicians in FL, where the typical reported total is $2,085.

$2,480in general payments, 2019–2025

Across 76 payments — averaging $32.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Curonix LLC$631
  • Stimwave Technologies Incorporated$340
  • Scilex Pharmaceuticals Inc.$229
  • Medtronic$201
  • Abbott$194
  • Nevro Corp.$185
  • plus $700 from 13 others
$1,621,021in research payments, 2019–2025

Across 478 payments — averaging $3391.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Akebia Therapeutics Inc$383K
  • AstraZeneca$365K
  • Merck$339K
  • Novavax Inc$243K
  • AbbVie$115K
  • OPKO Pharmaceuticals, LLC$58K
  • plus $118K from 5 others

What the payments were for

  • Travel & lodging$30512%
  • Food & beverage$2,17588%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,480 in reported general payments places this provider in the 50th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$84,911
Medicare patients
132
Services billed
5,292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl48$4,610
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen109$3,079
Tramadol Hcl119$643
Acetaminophen-CodeineAcetaminophen With Codeine32$566
Diclofenac Sodium37$454
Methylprednisolone59$403
Pregabalin16$344
Gabapentin35$246
Promethazine Hcl13$227
Celecoxib14$219
Cyclobenzaprine Hcl26$213
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen17$166
Oxycodone Hcl27$161
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$148
Hydromorphone Hcl27$118

Paid to pharmacies, not to this prescriber.

Other pain medicine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →